Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAID: Antibiotic Duration for CIED Lead Infections
NCT06203769Phase 4Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2024
- Primary completion
- Jan 2028
01
Overview
Phase 4, randomised, open-label trial in cardiac implantable electronic device infection (CIEDI) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Mortality at 3 months, Rate of relapse of infection at 6 months and 1 more. Planned start Jun 2024; status: not yet recruiting.
02
Conditions
cardiac implantable electronic device infection (CIEDI)
Beyond the preview
Go deeper on NCT06203769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06203769.